Description
Is Trastuzumab Injection available in India?
Yes, Trastuzumab Injection is available in India. It is marketed under the brand name Hervycta among others. It is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
The new indications are:
HER2-Low Metastatic Breast Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with unresectable or metastatic HER2-Low breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.
Locally Advanced or Metastatic Gastric Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab based regimen.
Trastuzumab deruxtecan was earlier approved by Drug Controller General of India (DCGI), for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen.
Approved in May 2023 for the treatment of metastatic breast cancer. In March 2024, the Central Drugs Standard Control Organisation (CDSCO) approved the drug for two additional indications: HER2-low metastatic breast cancer and HER2-positive gastric cancer.
Who is the CFA, distributor, and retailer for Hervycta (Trastuzumab) Injection in India?
Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Hervycta (Trastuzumab) Injections in India. It is marketed by Dr Reddy’s. Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Dr Reddy’s products, including advanced cancer treatments.
The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup.
How much do Hervycta Injection cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
Prior to consuming any medications, including Trastuzumab Injection, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
List of available brand-name drugs in India for Trastuzumab Injection
Branded Generic Drugs for Trastuzumab Injection: Biceltis | Canmab | Eleftha | Herclon | Hermab | Hersima Hertraz | Hervycta | Trasturel | Trazumab | Trumab | Ujvira
NEWS / UPDATES
- Aurobindo Pharma secures marketing authorisation for Trastuzumab biosimilar in India.
- AstraZeneca India receives CDSCO approval for sale, distribution of Trastuzumab.
- Trastuzumab Biosimilar, Hervycta, Launches in India.
- India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients.
- Generic Herceptin Approved in India.
- Roche-Launches-2-In-1-Biotech-Drug-For-Breast-Cancer-In-India.
- Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India.
- Roche Pharma launches PHESGO in India for the treatment of HER-2 positive breast .
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
05 March 2026 | 10:10 AM (IST)
